跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
佑尔健 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Haemorrhagic Fever with Renal Syndrome Bivalent Vaccine(Gerbil Kidney Cell),Inactivated
Approved
生物制品
Haemorrhagic Fever with Renal Syndrome Bivalent Vaccine(Gerbil Kidney Cell),Inactivated
浙江天元生物药业有限公司
🇨🇳 National Medical Products Administration
Approval Date
Jun 4, 2020
Approval ID
7LeaeGb1KMr
Company
浙江天元生物药业有限公司
Type
生物制品
Approval Details
Approval Id
7LeaeGb1KMr
Approval Number
国药准字S20050018
Generic Name
双价肾综合征出血热灭活疫苗(沙鼠肾细胞)
Generic Name En
Haemorrhagic Fever with Renal Syndrome Bivalent Vaccine(Gerbil Kidney Cell),Inactivated
Trade Name
佑尔健
Drug Type
生物制品
Dosage Form
注射剂
Strength
每瓶1.0ml,每1次人用剂量为1.0ml
Reg Date
2020-06-04
Company Name
浙江天元生物药业有限公司
Production Company Name
浙江天元生物药业有限公司
Production Company Address
杭州市余杭经济开发区天荷路56号
Company Detail Path
/organization/zhe-jiang-tian-yuan-sheng-wu-yao-ye-you-xian-gong-si
Production Company Detail Path
/organization/zhe-jiang-tian-yuan-sheng-wu-yao-ye-you-xian-gong-si
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Jun 4, 2020
Approval ID
7LeaeGb1KMr
Type
生物制品
Back to NMPA Approvals